Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy ; volume:19 ; number:1 ; day:1 ; month:11 ; year:2019 ; pages:1-12 ; date:12.2019
BMC cancer ; 19, Heft 1 (1.11.2019), 1-12, 12.2019
- Creator
-
Trotsyuk, Iryna
Sparschuh, Halina
Müller, Alice Josephine
Neumann, Konrad
Kruschewski, Martin
Horst, David
Elezkurtaj, Sefer
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6261-5
- URN
-
urn:nbn:de:101:1-2020022920001320941892
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Trotsyuk, Iryna
- Sparschuh, Halina
- Müller, Alice Josephine
- Neumann, Konrad
- Kruschewski, Martin
- Horst, David
- Elezkurtaj, Sefer
- SpringerLink (Online service)
Other Objects (12)
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy